Abstract
The clinical pattern determined in subjects that undergo a high and prolonged pressure regime is defined as “hypertensive disease”.
Keywords
- Arterial Hypertension
- Essential Hypertension
- Antihypertensive Treatment
- Resistant Hypertension
- Intermittent Claudication
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
A. B. Atkinson, J. Brown, A. F. Lever, J. I. S. Robertson, Combined treatment of severe intractable hypertension with Captopril and diuretic. Lancet 8186:105 (1980).
A. B. Atkinson, J. J. Morton, J. Brown, D. L. Davies, R. Fraser, P. Kelly, B. Leckie, A. F. Lever, J. I. S. Robertson, Captopril in clinical hypertension. Changes in componentes of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme. Br.Heart J. 44:290 (1980).
S. A. Atlas, D. B. Case, J. E. Sealey, J. H. Laragh, D. N. McKinstry, Interruption of the renin-angiotensin system in hypertensive patients by Captopril induces sustained production in aldosterone secretion, potassium retention and natriuresis. Hypertension 1:274 (1979).
C. L. Berry, Hypertension and arterial development. Long-term consideration. Br. Heart J. 40:709 (1978)
C. A. Bloxham, D. G. Beevers, J. M. Walker, Malignant hypertension and cigarette smoking. Br.Med.J. 1:581 (1979.
C. Brater, S. Anderson, C. Muckleroy, Effects in normal subjects of long term administration of azosenide. Clin. Pharmacol. Ther. 26:437 (1979).
H. R. Brunner, H. Gavras, B. Waeber, S. C. Textor, G. A. Turini, J. P. Wanters, Clinical use of an orally acting converting enzyme inhibitor: Captopril. Hypertension 2:558 (1980).
C. J. Bulpitt, L. J. Beilin, P. Clifton, C. T. Dollery, G. S. Harper, E. C. Coles, J. S. S. Gear, B. F. Johnson, A. D. Munro-Faure, Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. hypertension care computing project. Lancet 8134:134 (1979).
C. Cavallaro, Modificazioni della parete arteriosa nell’aterosclerosi. In: “Cardiologia d’Oggi”, Vol. 1 p. 193, Mediche Scientifiche, ed., Torino, 1975).
A. W. Jr. Cowley, The concept of autoregulation of total blood flow and its role in hypertension. Am.J.Med. 68:906 (1980).
D. S. Davies, J. L. Reid, Central cardiovascular actions of clonidine. In: “Central Action of Drugs in Blood Pressure Regulation”, The Whitefriers Press, ed., London, (1975).
C. De Mey, D. Wellens, P. M. Vanhoutte, Fisiopathology and pharmacotherapy of occlusive arterial disorders. Angiology 30:433 (1979).
A. Ebringer, A. E. Doyle, T. R. Dawborn, Clonidine in the treatment of hypertension. Br. Med. J. 1:402 (1971).
B. Fagrell, Digital pulse plethysmography and digital blood pressure measurement in the evaluation of arterial circulation in the lower limbs. Scand. J. Clin. Lab. Invest. 31:128 (1973).
K. Roger, R. K. Ferguson, H. Peter, J. Vlasses, D. Pharm, R. Janice, R. N. Kojlin, B. S. Anne Shirinian, F. James, J. Burke, C. John, R. Alexander, Captopril in severe treatment-resistant hypertension. Am. Heart J. 99:579 (1980).
S. Forconi, A. Jagenau, M. Guerrini, S. Pecchi, R. Cappelli, Strain-gauge plethysmography in the study of circulation of the limbs. Angiology 30:487 (1979).
W. I. Frishman, S. Halprin, Clinical pharmacology of the new beta-adrenergic blocking drugs. VII. New Horizons in beta-adrenoceptor blockade therapy: Labetalol. Am. Heart J. 98:660 (1979).
H. Gravas, Antihypertensive effects of the oral angiotensin converting-enzyme inhibitor. New Engl. J. Med. 298:991 (1978).
R. M. Greenhangh, D. S. Rosengarten, I. Mervert, B. Lewis, J. S. Colman, P. Martin, Serum lipids and lipoproteins in peripheral vascular desease. Lancet 2:947 (1971).
B. Gribbin, T. G. Pickerilg, P. Sleight, Arterial distensibility in normal and ipertensive man. Clin. Sci. 56:413 (1979).
L. Hansson, S. N. Hunyor, S. Julius, S. W. Hobler, Blood pressure crisis following withdrawal of Clonidine. Am. Heart J. 85:605 (1973).
S. W. Hoobler and E. Sagastume, Clonidine hydrochloride in the treatment of hypertension. Am. J. Cardiol. 28:67 (1971).
W. G. Hughson, J. Mann and A. Garrod, Intermittent claudication: prevalence and risk factors. Br. Med. J. 1:1379 (1978).
K. Hutchinson and H. Williams, Calf blood flow and ankle systolic blood pressure in intermittent claudication monitored over five years. Angiology 29:719 (1978).
R. G. Hutchinson, Medical management of hypertension. Angiology 30:558 (1979).
G. Koch, Haemodynamic effects of combined alpha and beta-adrenoceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Br. J. Clin. Pharmacol. 3(Suppl.):725 (1976).
G. Koch, Effetti emodinamici del blocco alfa e beta-recettoriale acuto con somministrazione di labetalolo e.v. e variazioni in corso di trattamento orale protratto in pazienti affetti da ipertensione essenziale. in: “Atti Convegno Venezia”, p.65 (1978).
H. Koffer, P. H. Vlasses, R. K. Ferguson, M. Weiss and A. G. Abler, Captopril in diuretic treated hypertensive patients. J.A.M.A. 244:2532 (1980).
B. O. Kristensen and J. Skork, Captopril or frusemide in drug-resistant hypertension (Letter) Lancet 8196:699 (1980).
D. W. Johns, K. M. Baker, C. R. Ayers, E. D. Vanghau Jr., R. M. Carey, M. J. Peach, M. R. Yancey, E. M. Ortt and S. C. Williams, Acute and chronic effect of Captopril in hypertensive patients. Hypertension 2:567 (1980).
C. L. Johnson, B. P. McGrath, J. A. Miller and P. G. Mathews, Long term effects of Captopril (SQ 14 225) on blood pressure and hormone levels in essential hypertension. Lancet 8141:493 (1979).
P. Lijnen, R. Fagard, J. Staessen, L. J. Verschueren and A. Amery, Dose response in Captopril therapy of hypertension. Clin. Pharmacol. Ther. 28:310 (1980).
G. M. London, M. E. Safar, Y. A. Weiss and A. Simon, Total effective Compliance of the vascular bed in essential hypertension. Am. Heart J. 95:325 (1978).
G. A. McGregor, N. D. Markandu, J. E. Roulston and J. C. Jones, Essential hypertension: effect of an oral inhibitor of angiotensin converting enzyme. Br. Med. J. 2:1106 (1979).
A. Maruyama, T. Ogihara, T. Naka, H. Mikami, T. Hata, M. Nakamaru, K. Iwanaga and Y. Kumahara, Long term effects of Captopril in hypertension. Clin. Pharmacol. Ther. 28:316 (1980).
G. Mattioli, S. Ricci and P. Bertoncelli, Haemodynamics of hypertension. Changes caused by beta blocking agents. Minerva Cardioangiol. 27:463 (1979).
P. Mayer, J. L. Elghozi and J. P. Grünfield, The physiological basis of the treatment of arterial hypertension. Nouv. Presse Med. 8:2325 (1979).
F. Messerly, J. De Carvalho, B. Christie and B. Fröhlich, Systemic and regional haemodynamics in low, normal and high cardiac output borderline hypertension. Circulation 58:441 (1978).
J. Metha and J. N. Cohn, Haemodynamic effects of labetalol, an alpha and beta-adrenoceptor blocking agent, in hypertensive subjects. Circulation 55:370 (1977).
C. Alicandri, E. Agabiti-Rosci, R. Fariello, L. Corea and B. Muiesan, Effetti emodinamici della somministrazione acuta e cronica del labetalolo nell’ipertensione arteriosa. in: “Atti Convegno Venezia”, p.31 (1978).
K. D. Boch, P. Merguet and V. H. Heimsoth, Effect of Clonidine on regional blood flow and its use in the treatment of hypertension, in: “Hypertension: Mechanisms and Management”, G. Onesti, K.E. Kim and J.A. Mayer eds., Grune and Stratton Inc. p.395 New York, (1973).
L. H. Opie, Drugs and the heart. III Calcium antagonist. Lancet 8172:806 (1980).
W. A. Pettinger, Clonidine a new antihypertensive drug. New. Engl. J. Med., 293:1179 (1975).
G. Thomas, T. G. Pickering, H. John and P. Laragh, Auto-regulation as a factor in peripheral resistance and flow: clinical implications for analysis of high blood pressure (editorial). Am.J.Med. 68:801 (1980).
A. Pinto, La semeiotica strumentale delle arteriopatie obliteranti degli arti inferiori. Coliana di quaderni monografici a cura di E. Massari. in: “Patologia arteriosa distrettuale”, E.S.I. Redaz. Stampa Medica.
B. N. C. Pichard, Beta-adrenoceptor blocking agents in the management of hypertension
L. E. Ramsay, Intermittent claudication in hypertensive men. Journal of the Royal College of Physicians of London 13:100 (1979).
J. L. Reid, H. J. Dargie and C. T. Dollery, Clonidine withdrawal in hypertension. Lancet 2:1171 (1977).
D. A. Richards and E. P. Wooding, The effects of oral AH 5158, a combined alpha and beta-adrenoceptor antagonist in healthy volunteers. Br. J. Clin. Pharmacol. 1:505 (1974).
A. Simon, B. Levy, Y. Weiss, M. Kheder and J. Levenson, Arterial compliance in permanent essential hypertension. Angiology 29:402 (1978).
A. Simon, M. A. Safar, J. Levenson, A. Kheder and B. Levy, Systolic hypertension: haemodynamic mechanism and choice of anti-hypertensive treatment. Am. J. Cardiol. 44:505 (1979).
J. Stamler, Prevenzione primaria e secondaria delle malattie aterosclerotiche. in: “Arteriosclerosi”, Vol.11, R. Paoletti and CR. Sirtori (Coord.), Ambrosiana, Milano, (1977).
R. Stamler, J. Stamler, W. F. Riedlinger, G. Algera and R. H. Roberts, Family (parental) history and prevalence of hypertension. Results of a nationwide screening program. J.A.M.A. 241:43 (1979).
A. Strano, S. Novo, G. Davi, A. Pinto and R. P. Riolo, Aspetti epidemiologici delle arteriopatie degli arti. in: “Giornate Angiologiche Fiorentine”, Firenze 14 Giugno (1979).
A. Strano, Fattori emodinamici nell’aterosclerosi. in: “Aterosclerosi: problemi di patologia e terapia”. Incontri con i medici 1977–1979, a cura della Direzione Medica Janssen.
A. Takeshita and A. L. Mark, Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hipertension 2:610 (1980).
P. A. Van Zwieten, The central action of antihypertensive drugs, mediated via central alpha-receptors. J. Pharm. Pharmaco1. 25:89 (1973).
J. K. Vyden, J. Thorner, K. Nagasewa, T. Takano, M. F. Groseth-Dittrich, R. Perlow and M. J. Swen, Metabolic and cardiovascular abnormalities in patients with peripheral arterial disease. Am. Heart J. 90:703 (1975).
P. Weidmann, R. De Chatle, W. H. Ziegler, J. Flammer and F. Reubi, Alpha and beta-adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and catecholamine excretion. Am. J. Cardiol. 41:570 (1978).
M. J. Wendeburg, Prolonged treatment of high renin hypertension with a converting enzyme inhibitor. Br. Med. J. 2:866 (1978).
L. Werko, Vascular adaptation to long term blood pressure reduction (Letter). Acta Med.Scand. 207:207 (1980).
A. Zanghetti, Overview of cardiovascular reflexes in hypertension. Am. J. Cardiol. 44:912 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Pinto, A. et al. (1984). Effects of Antihypertensive Treatment on Peripheral Flow of the Lower Limbs. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_29
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8616-2_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8618-6
Online ISBN: 978-1-4684-8616-2
eBook Packages: Springer Book Archive